Effects of premedication with Pronase for endoscopic ultrasound of the stomach: A randomized controlled trial

Table 1 Eligibility and exclusion criteria for this study

Eligibility criteria
1	Patients who required an EUS examination because of gastric diseases
2	Patients aged 18-70 yr
Exclusion criteria
1	Patients with contraindications to endoscopy
2	Patients allergic to the pharmaceutical ingredients
3	Patients with gastric bleeding or suspected gastric bleeding
4	Patients with blood coagulation dysfunction
5	Patients with severe psychological diseases such as depression, anxiety, hypochondria and hysteria
6	Patients with severe cardiac dysfunction (NYHA cardiac function classification ≥ class III)
7	Patients with abnormal hepatic function (serum ALT and AST levels of ≥ 4 times the upper normal limit)
8	Patients with renal dysfunction (serum Cr level of ≥ 2 times the upper normal limit)
9	Patients with moderate to severe ventilatory dysfunction
10	Diabetic patients with unsatisfactory glycemic control
11	Hypertensive patients with unsatisfactory blood pressure control
12	Pregnant women or women who are breastfeeding

ALT: Alanine aminotransferase; AST: Aspartate transaminase; Cr: Creatinine; EUS: Endoscopic ultrasonography; NYHA: New York Heart Association.